Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of noncoding RNAs in liver fibrosis
Qingyuan Li, Tao Gong, Yike Huang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 9, pp. 1446-1459
Open Access | Times Cited: 10

Showing 10 citing articles:

Why Is Wnt/β-Catenin Not Yet Targeted in Routine Cancer Care?
Auriane de Pellegars-Malhortie, Laurence Picque Lasorsa, Thibault Mazard, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 949-949
Open Access | Times Cited: 5
The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis
Kurt Sartorius, Ying Wang, Benn Sartorius, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Tumor microenvironment: new era in exosomal circRNA research - a bibliometric analysis
H Wang, Lu Zhang, Ming-Jie Li, et al.
Extracellular Vesicles and Circulating Nucleic Acids (2025) Vol. 6, Iss. 2, pp. 245-66
Open Access
Mechanisms of Epigenetic Regulation in the Fibrogenic Activation of Hepatic Stellate Cells in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Gene Expression (2024) Vol. 23, Iss. 1, pp. 31-43
Open Access | Times Cited: 3
Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 164-164
Open Access | Times Cited: 6
Signaling pathways that activate hepatic stellate cells during liver fibrosis
Youtian Zhang, Long Ren, Yinting Tian, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
Noncoding RNA network crosstalk in organ fibrosis
Hui Ling, Xian-Chen Wang, Zhiyan Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111430-111430
Closed Access | Times Cited: 1
Targeting Interleukin-17 as Novel Treatment Option for Fibrotic Diseases
Margherita Sisto, Sabrina Lisi
(2023)
Open Access | Times Cited: 3
Pathogenesis and clinical features of severe hepatitis E virus infection
László Orosz, Károly Péter Sárvári, Áron Dernovics, et al.
World Journal of Virology (2024) Vol. 13, Iss. 2
Open Access
Shugan Jianpi Formula attenuate liver fibrosis via regulation of miR-193a-3p/TGF-β2 in hepatic stellate cells: An in vivo and in vitro study
Qiumei Zhou, Xun Zhang, Sen Chen, et al.
Journal of Ethnopharmacology (2024), pp. 119120-119120
Closed Access
Serum Markers for Liver Fibrosis Assessment in Patients with Chronic Hepatitis B
杰 董
Advances in Clinical Medicine (2023) Vol. 13, Iss. 10, pp. 16863-16869
Closed Access
Page 1

Scroll to top